These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33391434)

  • 1. The Effect of Neoadjuvant Therapies for Patients with Locally Advanced Gastric Cancer: A Propensity Score Matching Study.
    Wang T; Chen Y; Zhao L; Zhou H; Wu C; Zhang X; Zhou A; Jin J; Zhao D
    J Cancer; 2021; 12(2):379-386. PubMed ID: 33391434
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
    Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer.
    He F; Yu L; Ding Y; Li ZH; Wang J; Zheng J; Chen HY; Liu S; Pang XL; Ajani JA; Wan XB
    Cancer Sci; 2020 Nov; 111(11):4205-4217. PubMed ID: 32860448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of different neoadjuvant treatment regimens in patients with locally advanced rectal cancer and MRI-detected extramural venous invasion.
    Chen M; Ma Y; Song YW; Huang J; Gao YH; Zheng J; He F
    Cancer Med; 2023 Nov; 12(21):20523-20537. PubMed ID: 37864414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology.
    Stiles BM; Kamel MK; Harrison SW; Rahouma M; Lee B; Nasar A; Port JL; Altorki NK
    Ann Thorac Surg; 2019 Jan; 107(1):187-193. PubMed ID: 30278165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-agent neoadjuvant chemotherapy improves response and survival in patients with resectable pancreatic cancer.
    Blinn P; Shridhar R; Maramara T; Huston J; Meredith K
    J Gastrointest Oncol; 2020 Oct; 11(5):1078-1089. PubMed ID: 33209499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis.
    Fan N; Wang Z; Zhou C; Bludau M; Contino G; Zhao Y; Bruns C
    EClinicalMedicine; 2021 Dec; 42():101183. PubMed ID: 34805809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?
    Yeh JH; Yeh YS; Tsai HL; Huang CW; Chang TK; Su WC; Wang JY
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching.
    Jing SW; Zhai C; Zhang W; He M; Liu QY; Yao JF; Wang R; Tian ZQ; Wang J; Liu JF
    Front Immunol; 2022; 13():970534. PubMed ID: 36275724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study.
    Han YM; Qi WX; Wang SB; Cao WG; Chen JY; Cai G
    Cancer Med; 2023 Jun; 12(12):13309-13318. PubMed ID: 37148548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.
    Zhu S; Brodin NP; English K; Ohri N; Chuy JW; Rajdev LN; Narang R; Kalnicki S; Guha C; Garg MK; Kabarriti R
    EClinicalMedicine; 2019 Nov; 16():23-29. PubMed ID: 31832617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study.
    Zhao J; Hao S; Tian J; Li Y; Han D
    J Inflamm Res; 2023; 16():3351-3363. PubMed ID: 37576156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant therapy and pancreatic cancer: a national cancer database analysis.
    Shridhar R; Takahashi C; Huston J; Meredith KL
    J Gastrointest Oncol; 2019 Aug; 10(4):663-673. PubMed ID: 31392047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between upfront surgery and neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A systematic review.
    Fiflis S; Papakonstantinou M; Giakoustidis A; Christodoulidis G; Louri E; Papadopoulos VN; Giakoustidis D
    World J Gastrointest Surg; 2023 Aug; 15(8):1808-1818. PubMed ID: 37701690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant Chemoradiotherapy Versus Chemotherapy for the Treatment of Locally Advanced Esophageal Adenocarcinoma in the European Multicenter ENSURE Study.
    Elliott JA; Klevebro F; Mantziari S; Markar SR; Goense L; Johar A; Lagergren P; Zaninotto G; van Hillegersberg R; van Berge Henegouwen MI; Schäfer M; Nilsson M; Hanna GB; Reynolds JV;
    Ann Surg; 2023 Nov; 278(5):692-700. PubMed ID: 37470379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Treatment Strategies for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Triple Cohort Analysis Using Propensity Score Matching.
    Han D; Tian J; Zhao J; Hao S
    Int J Gen Med; 2023; 16():5467-5479. PubMed ID: 38021055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma.
    Chen Y; Wu X; Hao D; Cheng X; Zhang L; Zhang Y; Ke S; Shi W; He C
    Oncotarget; 2019 Jun; 10(40):4069-4078. PubMed ID: 31258850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.